Leadership, Administration and Statisitical Analysis

领导、管理和统计分析

基本信息

  • 批准号:
    7786701
  • 负责人:
  • 金额:
    $ 45.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-04-01 至 2015-03-31
  • 项目状态:
    已结题

项目摘要

The goal of Core D Is to provide the leadership, administrative oversight as well as statistical analysis and related quality control to insure the completion of the specific aims of Projects 1 through 4, as well as the successful continuance of the Nurses' Health Study cohort. The specific aims are as follows: 1. To provide overall leadership to the Program Project and the Nurses' Health Study. 2. To provide administrative oversight for the Program Project. 3. To provide statistical expertise and programming support to insure the completion of Project 1-4 aims. 4. To maintain and further develop quality control measures related to data analysis and documentation. 5. To support and facilitate use of Nurses' Health Study resources by collaborating scientists. In Core D, we provide the structure and resources to facilitate continued communication between all Cores and Projects, as well as all investigators working with the cohort. The Core coordinates the regular bi-weekly meeting of NHS investigators as well as the annual meeting of the External Advisory Committee. All Program Project-related IRB activities are conducted through this core. We also provide a framework for data analyses as well as specific biostatistical support for Projects 1-4; computer programming is provided under the direction of study biostatisticians and project investigators. In addition, the Core provides an ongoing program of quality control and data documentation that are necessary to help insure that all users of the NHS data base are knowledgeable and aware of both its strengths and limitations, and publications are accurate and error free. Finally, by providing support for all initial queries from potential collaborators as well as data documentation, the Core facilitates the use of the Nurses' Health Study research platform for a range of scientific collaborations.
核心D的目标是提供领导,行政监督以及统计分析和相关的质量控制,以确保项目1至4的具体目标的完成,以及护士健康研究队列的成功延续。具体目标如下: 1.全面领导计划项目和护士健康研究。 2.为项目提供行政监督。 3.提供统计专业知识和规划支持,以确保项目1-4目标的完成。 4.维护和进一步发展与数据分析和文件相关的质量控制措施。 5.支持和促进合作科学家使用护士健康研究资源。 在核心D中,我们提供结构和资源,以促进所有核心和项目以及与队列合作的所有研究者之间的持续沟通。核心协调国民保健制度调查员的双周例会以及外部咨询委员会的年度会议。所有与计划项目相关的IRB活动均通过此核心进行。我们还为项目1-4提供数据分析框架和具体的生物统计支持;计算机编程在研究生物统计学家和项目调查员的指导下提供。此外,核心提供了一个持续的质量控制和数据文件,这是必要的,以帮助确保所有用户的国民保健服务数据库的知识和了解其优势和局限性,出版物是准确和无错误的。最后,通过为潜在合作者的所有初始查询以及数据文档提供支持,核心促进了护士健康研究研究平台在一系列科学合作中的使用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Susan E Hankinson其他文献

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer
全基因组关联研究确定了与胰腺癌易感性相关的 ABO 基因座的变体
  • DOI:
    10.1038/ng.429
  • 发表时间:
    2009-08-02
  • 期刊:
  • 影响因子:
    29.000
  • 作者:
    Laufey Amundadottir;Peter Kraft;Rachael Z Stolzenberg-Solomon;Charles S Fuchs;Gloria M Petersen;Alan A Arslan;H Bas Bueno-de-Mesquita;Myron Gross;Kathy Helzlsouer;Eric J Jacobs;Andrea LaCroix;Wei Zheng;Demetrius Albanes;William Bamlet;Christine D Berg;Franco Berrino;Sheila Bingham;Julie E Buring;Paige M Bracci;Federico Canzian;Françoise Clavel-Chapelon;Sandra Clipp;Michelle Cotterchio;Mariza de Andrade;Eric J Duell;John W Fox Jr;Steven Gallinger;J Michael Gaziano;Edward L Giovannucci;Michael Goggins;Carlos A González;Göran Hallmans;Susan E Hankinson;Manal Hassan;Elizabeth A Holly;David J Hunter;Amy Hutchinson;Rebecca Jackson;Kevin B Jacobs;Mazda Jenab;Rudolf Kaaks;Alison P Klein;Charles Kooperberg;Robert C Kurtz;Donghui Li;Shannon M Lynch;Margaret Mandelson;Robert R McWilliams;Julie B Mendelsohn;Dominique S Michaud;Sara H Olson;Kim Overvad;Alpa V Patel;Petra H M Peeters;Aleksandar Rajkovic;Elio Riboli;Harvey A Risch;Xiao-Ou Shu;Gilles Thomas;Geoffrey S Tobias;Dimitrios Trichopoulos;Stephen K Van Den Eeden;Jarmo Virtamo;Jean Wactawski-Wende;Brian M Wolpin;Herbert Yu;Kai Yu;Anne Zeleniuch-Jacquotte;Stephen J Chanock;Patricia Hartge;Robert N Hoover
  • 通讯作者:
    Robert N Hoover

Susan E Hankinson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Susan E Hankinson', 18)}}的其他基金

Metabolomic profile of chronic distress in relation to diseases of aging across diverse populations
不同人群中与衰老疾病相关的慢性痛苦的代谢组学特征
  • 批准号:
    10584230
  • 财政年份:
    2017
  • 资助金额:
    $ 45.43万
  • 项目类别:
Endogenous hormones and postmenopausal breast cancer: Etiologic insights and improving risk prediction
内源性激素和绝经后乳腺癌:病因学见解和改进风险预测
  • 批准号:
    9899942
  • 财政年份:
    2017
  • 资助金额:
    $ 45.43万
  • 项目类别:
Assessing the role of androgens in breast cancer risk
评估雄激素在乳腺癌风险中的作用
  • 批准号:
    8692673
  • 财政年份:
    2012
  • 资助金额:
    $ 45.43万
  • 项目类别:
Assessing the role of androgens in breast cancer risk
评估雄激素在乳腺癌风险中的作用
  • 批准号:
    8273845
  • 财政年份:
    2012
  • 资助金额:
    $ 45.43万
  • 项目类别:
Assessing the role of androgens in breast cancer risk
评估雄激素在乳腺癌风险中的作用
  • 批准号:
    8517054
  • 财政年份:
    2012
  • 资助金额:
    $ 45.43万
  • 项目类别:
Premonopausal Hormone Levels and Risk of Breast Cancer
绝经前激素水平和乳腺癌风险
  • 批准号:
    7844510
  • 财政年份:
    2009
  • 资助金额:
    $ 45.43万
  • 项目类别:
HORMONES, DIET AND RISK OF OVARIAN CANCER
激素、饮食和卵巢癌风险
  • 批准号:
    7072372
  • 财政年份:
    2004
  • 资助金额:
    $ 45.43万
  • 项目类别:
Modifiable Risk Factors and Gene/Environment interactions in Ovarian Cancer
卵巢癌中可改变的危险因素和基因/环境相互作用
  • 批准号:
    6991014
  • 财政年份:
    2004
  • 资助金额:
    $ 45.43万
  • 项目类别:
URINARY ESTROGEN METABOLITES AND BREAST CANCER RISK
尿液雌激素代谢物与乳腺癌风险
  • 批准号:
    6377888
  • 财政年份:
    2000
  • 资助金额:
    $ 45.43万
  • 项目类别:
Dietary and Hormonal Determinants of Cancer in Women
女性癌症的饮食和激素决定因素
  • 批准号:
    7283744
  • 财政年份:
    2000
  • 资助金额:
    $ 45.43万
  • 项目类别:

相似海外基金

Intelligent Breast Cancer DiagnOsis and MonItoring Therapeutic Response Training Network (CanDoIt)
智能乳腺癌诊断和监测治疗反应训练网络(CanDoIt)
  • 批准号:
    EP/Y03693X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.43万
  • 项目类别:
    Research Grant
From single-cell transcriptomic to single-cell fluxomic: characterising metabolic dysregulations for breast cancer subtype classification
从单细胞转录组到单细胞通量组:表征乳腺癌亚型分类的代谢失调
  • 批准号:
    EP/Y001613/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.43万
  • 项目类别:
    Research Grant
Preclinical validation of synthetic biomolecules to treat Breast Cancer from AI-enabled discovery of novel lncRNA therapeutic targets.
通过人工智能发现新型 lncRNA 治疗靶点,对合成生物分子治疗乳腺癌进行临床前验证。
  • 批准号:
    10110204
  • 财政年份:
    2024
  • 资助金额:
    $ 45.43万
  • 项目类别:
    Launchpad
Quad negative breast cancerに対する新たなプレシジョン・メディシン治療戦略
四阴性乳腺癌精准医学治疗新策略
  • 批准号:
    24K11748
  • 财政年份:
    2024
  • 资助金额:
    $ 45.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ESR1 mutation profiling identifies potential drivers of metastatic breast cancer
ESR1 突变分析确定了转移性乳腺癌的潜在驱动因素
  • 批准号:
    MR/X018199/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.43万
  • 项目类别:
    Research Grant
Spatial-BrTME: Multicellular spatial dynamics of immunotherapy response in breast cancer
Spatial-BrTME:乳腺癌免疫治疗反应的多细胞空间动力学
  • 批准号:
    EP/Y014995/1
  • 财政年份:
    2024
  • 资助金额:
    $ 45.43万
  • 项目类别:
    Research Grant
Development of comprehensive PET imaging for precise diagnosis of breast cancer
开发用于乳腺癌精确诊断的综合PET成像
  • 批准号:
    23H02856
  • 财政年份:
    2023
  • 资助金额:
    $ 45.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of internal radiation therapy agents for refractory breast cancer based on phase-shift using focused ultrasound
基于聚焦超声相移的难治性乳腺癌体内放射治疗剂的开发
  • 批准号:
    23H02866
  • 财政年份:
    2023
  • 资助金额:
    $ 45.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The early detection of breast cancer using field cacerization.
使用现场癌症化早期检测乳腺癌。
  • 批准号:
    23K08094
  • 财政年份:
    2023
  • 资助金额:
    $ 45.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of CD44 bearing TJA-II binding glycans in therapy-resistant subset of triple negative breast cancer
携带 CD44 的 TJA-II 结合聚糖在三阴性乳腺癌耐药亚型中的作用
  • 批准号:
    23K06748
  • 财政年份:
    2023
  • 资助金额:
    $ 45.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了